CONTEXT: There is little information on the potential impact of serum 1,25-dihydroxyvitamin D [1,25(OH)2D] on bone health including turnover. OBJECTIVE: The objective of the study was to determine the influence of 1,25(OH)2D and 25-hydroxyvitamin D [25(OH)D] on bone health in middle-aged and older European men. DESIGN, SETTING, AND PARTICIPANTS: Men aged 40-79 years were recruited from population registers in 8 European centers. Subjects completed questionnaires that included questions concerning lifestyle and were invited to attend for quantitative ultrasound (QUS) of the heel, assessment of height and weight, and a fasting blood sample from which 1,25(OH)2D, 25(OH)D, and PTH were measured. 1,25(OH)2D was measured using liquid chromatography tandem mass spectrometry. Bone markers serum N-terminal propeptide of type 1 procollagen (P1NP) and crosslinks (β-cTX) were also measured. Dual-energy x-ray absorptiometry (DXA) of the hip and lumbar spine was performed in 2 centers. MAIN OUTCOME MEASURE(S): QUS of the heel, bone markers P1NP and β-cTX, and DXA of the hip and lumbar spine were measured. RESULTS: A total of 2783 men, mean age 60.0 years (SD 11.0) were included in the analysis. After adjustment for age and center, 1,25(OH)2D was positively associated with 25(OH)D but not with PTH. 25(OH)D was negatively associated with PTH. After adjustment for age, center, height, weight, lifestyle factors, and season, 1,25(OH)2D was associated negatively with QUS and DXA parameters and associated positively with β-cTX. 1,25(OH)2D was not correlated with P1NP. 25(OH)D was positively associated with the QUS and DXA parameters but not related to either bone turnover marker. Subjects with both high 1,25(OH)2D (upper tertile) and low 25(OH)D (lower tertile) had the lowest QUS and DXA parameters and the highest β-cTX levels. CONCLUSIONS: Serum 1,25(OH)2D is associated with higher bone turnover and poorer bone health despite being positively related to 25(OH)D. A combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.
CONTEXT: There is little information on the potential impact of serum 1,25-dihydroxyvitamin D [1,25(OH)2D] on bone health including turnover. OBJECTIVE: The objective of the study was to determine the influence of 1,25(OH)2D and 25-hydroxyvitamin D [25(OH)D] on bone health in middle-aged and older European men. DESIGN, SETTING, AND PARTICIPANTS: Men aged 40-79 years were recruited from population registers in 8 European centers. Subjects completed questionnaires that included questions concerning lifestyle and were invited to attend for quantitative ultrasound (QUS) of the heel, assessment of height and weight, and a fasting blood sample from which 1,25(OH)2D, 25(OH)D, and PTH were measured. 1,25(OH)2D was measured using liquid chromatography tandem mass spectrometry. Bone markers serum N-terminal propeptide of type 1 procollagen (P1NP) and crosslinks (β-cTX) were also measured. Dual-energy x-ray absorptiometry (DXA) of the hip and lumbar spine was performed in 2 centers. MAIN OUTCOME MEASURE(S): QUS of the heel, bone markers P1NP and β-cTX, and DXA of the hip and lumbar spine were measured. RESULTS: A total of 2783 men, mean age 60.0 years (SD 11.0) were included in the analysis. After adjustment for age and center, 1,25(OH)2D was positively associated with 25(OH)D but not with PTH. 25(OH)D was negatively associated with PTH. After adjustment for age, center, height, weight, lifestyle factors, and season, 1,25(OH)2D was associated negatively with QUS and DXA parameters and associated positively with β-cTX. 1,25(OH)2D was not correlated with P1NP. 25(OH)D was positively associated with the QUS and DXA parameters but not related to either bone turnover marker. Subjects with both high 1,25(OH)2D (upper tertile) and low 25(OH)D (lower tertile) had the lowest QUS and DXA parameters and the highest β-cTX levels. CONCLUSIONS: Serum 1,25(OH)2D is associated with higher bone turnover and poorer bone health despite being positively related to 25(OH)D. A combination of high 1,25(OH)2D and low 25(OH)D is associated with the poorest bone health.
Authors: P Srikanth; R F Chun; M Hewison; J S Adams; R Bouillon; D Vanderschueren; N Lane; P M Cawthon; T Dam; E Barrett-Connor; L B Daniels; J M Shikany; M L Stefanick; J A Cauley; E S Orwoll; C M Nielson Journal: Osteoporos Int Date: 2016-02-23 Impact factor: 4.507
Authors: M R Laurent; M J Cook; E Gielen; K A Ward; L Antonio; J E Adams; B Decallonne; G Bartfai; F F Casanueva; G Forti; A Giwercman; I T Huhtaniemi; K Kula; M E J Lean; D M Lee; N Pendleton; M Punab; F Claessens; F C W Wu; D Vanderschueren; S R Pye; T W O'Neill Journal: Osteoporos Int Date: 2016-06-07 Impact factor: 4.507
Authors: Agnieszka Prytuła; Johan Vande Walle; Hans Van Vlierberghe; Jean-Marc Kaufman; Tom Fiers; Jo Dehoorne; Ann Raes Journal: Endocrine Date: 2015-10-03 Impact factor: 3.633
Authors: Christine M Swanson; Priya Srikanth; Christine G Lee; Steven R Cummings; Ivo Jans; Jane A Cauley; Roger Bouillon; Dirk Vanderschueren; Eric S Orwoll; Carrie M Nielson Journal: J Bone Miner Res Date: 2015-05-22 Impact factor: 6.741
Authors: Ludmila Brunerová; Renata Lažanská; Petr Kasalický; Jana Verešová; Jana Potočková; Alena Fialová; Ivan Rychlík Journal: Int Urol Nephrol Date: 2018-08-16 Impact factor: 2.370
Authors: Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson Journal: Endocr Rev Date: 2014-09-09 Impact factor: 19.871
Authors: Christine M Swanson; Carrie M Nielson; Smriti Shrestha; Christine G Lee; Elizabeth Barrett-Connor; Ivo Jans; Jane A Cauley; Steven Boonen; Roger Bouillon; Dirk Vanderschueren; Eric S Orwoll Journal: J Clin Endocrinol Metab Date: 2014-05-14 Impact factor: 5.958
Authors: Margot J Overman; Neil Pendleton; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Giulia Rastrelli; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Margus Punab; David M Lee; Elon S Correa; Tomas Ahern; Sabine M P Verschueren; Leen Antonio; Evelien Gielen; Martin K Rutter; Dirk Vanderschueren; Frederick C W Wu; Jos Tournoy Journal: Eur J Nutr Date: 2016-07-01 Impact factor: 5.614
Authors: E Gielen; T O'Neill; S Pye; J Adams; K Ward; F Wu; M Laurent; F Claessens; S Boonen; D Vanderschueren; S Verschueren Journal: Osteoporos Int Date: 2014-09-16 Impact factor: 4.507